BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3670981)

  • 1. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics; 1996 Aug; 98(2 Pt 1):301-4. PubMed ID: 8692637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant medication and short attention span: a clinical approach.
    Davy T; Rodgers CL
    J Dev Behav Pediatr; 1989 Dec; 10(6):313-8. PubMed ID: 2513337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperkinetic disorders with attention deficit. Diagnostic and therapeutic approach].
    Vallée L; Pandit F
    Pediatrie; 1991; 46(11):719-29. PubMed ID: 1661401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
    Walkup JT; Scahill LD; Riddle MA
    Adv Neurol; 1995; 65():259-72. PubMed ID: 7872144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug treatment for hyperactive children. Therapeutic guidelines.
    Elia J
    Drugs; 1993 Nov; 46(5):863-71. PubMed ID: 7507036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hyperkinetic child: current status.
    Dubey DR
    Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 16. Attention deficit hyperactivity disorder: does it affect adults too?
    Heath CT; Wright HH; Batey SR
    South Med J; 1990 Dec; 83(12):1396-401. PubMed ID: 2251528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood levels and tolerance to stimulants in ADDH children.
    Swanson JM; Lerner M; Cantwell D
    Clin Neuropharmacol; 1986; 9 Suppl 4():523-5. PubMed ID: 3567959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.